Skip to content

Precigen PGEN Other intangible assets—net

Other intangible assets—net at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$18.24B-18.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$1.29B+10.3%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$174M-1.4%
Gilead Sciences logo
Gilead SciencesGILD
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Amgen logo
AmgenAMGN

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's other intangible assets—net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's other intangible assets—net?
Precigen (PGEN) reported other intangible assets—net of $2.86M in Q1 2026.
How has Precigen's other intangible assets—net changed year-over-year?
Precigen's other intangible assets—net decreased by 30.8% year-over-year, from $4.14M to $2.86M.
What is the long-term trend for Precigen's other intangible assets—net?
Over 5 years (2020 to 2025), Precigen's other intangible assets—net has grown at a -45.4% compound annual growth rate (CAGR), from $65.4M to $3.18M.
What does other intangible assets—net mean?
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.